key: cord-0710929-ric123ve
authors: Suetens, Carl; Kinross, Pete; Gallego Berciano, Pilar; Arroyo Nebreda, Virginia; Hassan, Eline; Calba, Clémentine; Fernandes, Eugenia; Peralta-Santos, Andre; Casaca, Pedro; Shodu, Nathalie; Dequeker, Sara; Kontopidou, Flora; Pappa, Lamprini; Kacelnik, Oliver; Børseth, Anita Wang; O’Connor, Lois; Garvey, Patricia; Liausedienė, Rasa; Valintelienė, Rolanda; Ernst, Corinna; Mossong, Joël; Štefkovičová, Mária; Prostináková, Zuzana; Danielsen, Ann Caroline; Mougkou, Aikaterini; Lamb, Favelle; Cenciarelli, Orlando; Monnet, Dominique L.; Plachouras, Diamantis
title: Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
date: 2021-12-09
journal: Euro Surveill
DOI: 10.2807/1560-7917.es.2021.26.49.2101070
sha: 050ed2adda3773f65780bcca81b72068bbcfd5b0
doc_id: 710929
cord_uid: ric123ve

We collected data from 10 EU/EEA countries on 240 COVID-19 outbreaks occurring from July−October 2021 in long-term care facilities with high vaccination coverage. Among 17,268 residents, 3,832 (22.2%) COVID-19 cases were reported. Median attack rate was 18.9% (country range: 2.8–52.4%), 17.4% of cases were hospitalised, 10.2% died. In fully vaccinated residents, adjusted relative risk for COVID-19 increased with outbreak attack rate. Findings highlight the importance of early outbreak detection and rapid containment through effective infection prevention and control measures.

We collected data from 10 EU/EEA countries on 240 COVID-19 outbreaks occurring from July−October 2021 in long-term care facilities with high vaccination coverage. Among 17,268 residents, 3,832 (22.2%) COVID-19 cases were reported. Median attack rate was 18.9% (country range: 2.8-52.4%), 17.4% of cases were hospitalised, 10.2% died. In fully vaccinated residents, adjusted relative risk for COVID-19 increased with outbreak attack rate. Findings highlight the importance of early outbreak detection and rapid containment through effective infection prevention and control measures.

In 2021, morbidity and mortality among residents in long-term care facilities (LTCFs) dramatically declined with the progressive increase of coronavirus disease (COVID-19) vaccine uptake, still, several outbreaks, including severe cases and deaths, continued to occur during the second part of 2021 [1] . We present data from 240 outbreaks of COVID-19 occurring between 5 July and 3 October 2021, in LTCFs with high vaccination coverage reported by 10 European Union and European Economic Area (EU/EEA) countries in September and October 2021.

The data collection followed a protocol developed by the European Centre for Disease Prevention and Control (ECDC) to (i) obtain data on COVID-19 outbreaks in LTCFs, (ii) assess the severity of breakthrough infections by vaccination status in LTCF residents and staff, and (iii) assess determinants of infection, hospitalisation and death [2] . Aggregate data were collected through the European surveillance portal for infectious diseases (EpiPulse). Data on COVID-19 outbreaks were reported on a voluntary basis, and included type of LTCF, starting date of the outbreak, ending date of the local vaccination campaign, vaccine product, testing strategy, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing results, and denominator data by vaccination status for residents and staff. Data on COVID-19 cases could either be reported as aggregate data by vaccination status, including the numbers of asymptomatic and symptomatic cases, hospitalised cases and deaths, or as case-based data. COVID-19 was defined according to the EU case definition [3] . We defined fully vaccinated as having completed the primary series of vaccination, with the number of doses according to manufacturers' recommendations. Data collection in LTCFs was coordinated by ECDC's national focal points in each country in collaboration with sub-national authorities in charge of outbreak investigations. An outbreak was defined as the occurrence of more than one confirmed COVID-19 case among LTCF residents within a period of 2 weeks, but focal points were also allowed to use national definitions. They were asked to include data on outbreaks irrespective of the number of cases involved.

Pooled attack rates were calculated by country as the sum of COVID-19 cases divided by the sum of residents, with 95% confidence intervals taking into account overdispersion or exact confidence intervals when only one outbreak was reported. The determinants of COVID-19 in LTCF residents were analysed using a mixed-effects generalised linear model with Poisson distribution, with country included as random effect. Adjusted relative risks (RRa) for vaccination against COVID-19 were calculated for fully vaccinated compared to unvaccinated, excluding those partially vaccinated. Confounding and effect modification was assessed for time since completion of vaccination, size and type of LTCF, country, and categories of outbreak attack rate (AR) in residents, calculated from the distribution of the ARs of the 240 outbreaks as AR quartiles with rounded category limits (<7.5%, 7.5 ≤ AR < 20%, 20 ≤ AR < 45%, ≥ 45%). The p value cut-off for statistical significance was set at 0.05 for main effects and at 0.10 for interaction terms. Twenty outbreaks with missing or discordant data for denominators and cases by vaccination status were excluded from the latter analysis.

Data on a total of 240 outbreaks occurring from July onwards were submitted to ECDC between 23 September and 13 October 2021 by 10 EU/EEA countries ( 

Data on LTCF staff were provided for 220 (91.7%) outbreaks ( Table 2 ). The median AR was 6.5% (IQR: 1.6-14.3). Of 831 cases among staff members, 11 (1.3%) cases were hospitalised and one (0.1%) died. Asymptomatic cases accounted for 39.7% of cases for 

SARS-CoV-2 sequencing results were available for 95 (39.6%) of 240 outbreaks from the 10 countries. The Delta variant of concern (VOC) was reported in 93 (97.9%) outbreaks, the Alpha VOC and the Gamma VOC each in one outbreak (Supplementary Table S2 ).

The determinants of COVID-19 and of COVID-19-related hospitalisation and death during outbreaks are shown in Tables 3 and 4 , respectively. There was a statistically significant interaction between the outbreak AR and being fully vaccinated against COVID-19, for COVID-19 in residents and staff (Table 3) and COVID-19-related hospitalisation, but not COVID-19-related death in residents ( 

Case-based data were provided for 2,074 COVID-19 cases by 103 LTCFs from Luxembourg (n = 4) and Spain (n = 99 

Our study shows that there is a risk for outbreaks of COVID-19 in LTCFs in EU/EEA countries despite very high uptake of the COVID-19 vaccine in LTCF residents (country mean: 95%) and high uptake in staff (country mean: 83.7%). In some cases, the outbreaks had a high AR and resulted in high morbidity and high mortality among residents. The risk for COVID-19-related hospitalisation and death was higher in large LTCFs than in small LTCFs, which may reflect a higher proportion of frail elderly people in large LTCFs or a higher number of contacts with staff and visitors. Our study also shows that, in fully vaccinated residents and staff, the risk for COVID-19 was much lower compared to unvaccinated residents and staff in outbreaks with an AR below 20%, but not in outbreaks with an AR of 20% or higher, which emphasises the need to rapidly detect and control outbreaks, even in LTCFs with a high vaccine uptake. The increased RR of infection for fully vaccinated residents and staff in outbreaks with a higher attack rate (20% or more) could be due to three underlying mechanisms. First, a high force of infection because of exposure to large viral loads might overcome the immune protection [4] . This could happen during superspreading events (e.g. a highly infectious index case with contacts with many residents) or with repeated exposure in large outbreaks where many residents and staff members are infected. A lower adherence of vaccinated staff and residents to infection prevention control measures such as wearing face masks and practicing hand hygiene, as well as allowing a larger number of visitors, may also contribute to the increased exposure. The observation that Ct values were low in outbreaks with high ARs seems to support a viral dose hypothesis, even though Ct values were only available for a limited number of cases and should be interpreted with caution. Second, this observation could result from differences in frailty in the resident populations in the included LTCFs that may not have been captured by the variables 'type of LTCF' and 'size of LTCF'. Finally, though very unlikely, there is the hypothetical possibility that issues with specific vaccine lots or the vaccine cold chain in LTCFs experiencing large outbreaks might explain this observation. However, none of the participating countries reported any issue that would support this hypothesis. All these hypotheses need to be investigated with appropriately designed vaccine effectiveness studies in LTCFs taking into account additional confounding factors such as underlying comorbidities and frailty of the residents.

Our study has several limitations. First, the reported RRa pertaining to vaccination must be interpreted with caution because of potential selection bias with only a small proportion of residents being unvaccinated. The reasons why these residents were not vaccinated are not known but could be related to factors such as previous infection and/or frailty that may have resulted in fewer contacts and a low AR among unvaccinated residents. A similar bias may have occurred in staff if unvaccinated staff members were more likely to have been previously infected than vaccinated staff members. However, the observed decrease of the effect of vaccination with increasing attack rates is unlikely to have been influenced by this limitation. Second, the hospitalisation data may have been affected by different policies and thresholds for hospitalisation of residents in different countries. Third, results on hospitalisation and death related to COVID-19 in unvaccinated residents should be interpreted with caution because of the low number of events in this category. Fourth, although most countries reported that they were screening all residents and staff in the entire LTCF or in the affected LTCF ward, we cannot exclude that differences in testing strategy may have affected the results. Fifth, the data do not allow to draw conclusions on either the effect of time from vaccination or the effect of the Delta VOC as most of the outbreaks in this study occurred from July to September 2021, which is not a sufficiently long period to show the effect of waning and which coincides with the period when the Delta VOC was predominant [5] . Therefore, the fact that time since the end of the vaccination campaign in early 2021 for most of the LTCF residents, was not significantly associated with the risk of COVID-19 in our study does not exclude that waning immunity played an important role in our findings.

Properly designed studies are needed to assess the effectiveness of COVID-19 vaccines in LTCF residents and the possible role of waning immunity following vaccination in this population. In the meantime, efforts should be made to reach maximum vaccination coverage in LTCF residents and staff. In addition, an additional vaccine dose has been linked to prolonging the immune response and broadening neutralisation against variant strains, including the Delta VOC [6] and studies from Israel and the United Kingdom showed lower rates of confirmed COVID-19 in persons aged 60 and older, or 50 years and older, respectively, after receiving an additional vaccine dose [7, 8] . Therefore, an additional dose should be considered for older frail individuals such as LTCF residents [9] and for staff in LTCFs. A recent mapping of vaccination recommendations in the EU/EEA indicated that 30 of 30 countries already started providing a booster dose of vaccine to LTCF residents as at November 2021 [10] .

Our results indicate that, despite high vaccination coverage, COVID-19 outbreaks continue to occur in LTCFs in the EU/EEA. They highlight the importance of early detection and rapid containment of COVID-19 outbreaks in LTCFs, thus to limit broad circulation of SARS-Cov-2, through rapid testing of all residents and staff, timely isolation of cases and ensuring strict infection prevention and control measures including appropriate ventilation, use of face masks, adherence to hand hygiene and the availability of resources to implement these measures. Finally, our findings also emphasise the importance of considering booster doses to protect this vulnerable population.

Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage

Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities, version 2.0. Stockholm: ECDC

Case definition for coronavirus disease 2019 (COVID-19), as of 3

Force of infection: a determinant of vaccine efficacy? NPJ Vaccines

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant -National Healthcare Safety Network

SARS-CoV-2 Neutralization with BNT162b2

Vaccine Dose 3

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Effectiveness of BNT162b2 (Comirnaty

COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study

Interim public health considerations for the provision of additional COVID-19 vaccine doses

Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA. Stockholm: ECDC;11

The authors would like to thank all colleagues involved in the data collection for this study at local, sub-national and national level in the participating EU/EEA countries.

None declared.

Carl Suetens: study design, data management and analysis, interpretation of results, drafting the paper, approval, agreement to be accountable; Dominique L. Monnet, Diamantis Plachouras: study design, interpretation of results, drafting, approval, agreement to be accountable;

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence and indicate if changes were made.Any supplementary material referenced in the article can be found in the online version.